By A Mystery Man Writer
Frontiers Triple-negative and Her2-positive breast cancer in
Landmark trials in breast cancer.pptx
A population-based study on the patterns of use of different
Breast Cancer Recurrence by Protocol: NSABP Protocols B-30, B-31
Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon
Preservation of Axillary Lymph Nodes Compared with Complete
21-Gene Recurrence Score and Locoregional Recurrence in Node
Controlling angiogenesis in breast cancer: A systematic review of
Immunological and clinicopathological features predict HER2
CONSORT 2010 explanation and elaboration: Updated guidelines for
The impact of erythropoiesis-stimulating agents administration
Cancers, Free Full-Text
Safety, activity, and molecular heterogeneity following
National Surgical Adjuvant Breast and Bowel Project (NSABP)
Consort diagram. ITT: intention to treat; *including two patients